Voyager Therapeutics, Inc. announced that Grace E. Col n, Ph.D., Catherine J. Mackey, Ph.D., Glenn Pierce, M.D., Ph.D., Michael Higgins,Jude Onyia, Ph.D, and Nancy Vitale will not stand for re-election as directors, at its Annual Meeting is to be held on June 6, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.525 USD | -3.13% |
|
+0.95% | +0.71% |
Jun. 13 | Voyager Therapeutics Names Nathan Jorgensen as Finance Chief | MT |
Jun. 13 | Voyager Therapeutics, Inc. Appoints Nathan Jorgensen as Chief Financial Officer, Effective July 8, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.71% | 479M | |
+39.80% | 55.66B | |
-8.43% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.03% | 26.29B | |
-15.49% | 20.25B | |
+30.76% | 12.76B | |
+26.78% | 12.18B | |
-1.81% | 12.12B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics, Inc. Announces Names of Directors Not Standing for Re-Election